Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
644
archived clinical trials in
Dental

Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla
Randomized, Controlled Clinical Study Comparing Submerged vs. Trans-mucosal Placement of P.004 Implants in the Anterior Maxilla and Mandible by Evaluation of the Change in Bone Level Between 1st Stage Surgery and 6 Months Post Surgery
Status: Enrolling
Updated:  3/2/2016
Dr. William C. Martin
mi
from
Gainesville, FL
Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla
Randomized, Controlled Clinical Study Comparing Submerged vs. Trans-mucosal Placement of P.004 Implants in the Anterior Maxilla and Mandible by Evaluation of the Change in Bone Level Between 1st Stage Surgery and 6 Months Post Surgery
Status: Enrolling
Updated: 3/2/2016
Dr. William C. Martin
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla
Randomized, Controlled Clinical Study Comparing Submerged vs. Trans-mucosal Placement of P.004 Implants in the Anterior Maxilla and Mandible by Evaluation of the Change in Bone Level Between 1st Stage Surgery and 6 Months Post Surgery
Status: Enrolling
Updated:  3/2/2016
Dr. Stephen T. Chen
mi
from
Melbourne,
Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla
Randomized, Controlled Clinical Study Comparing Submerged vs. Trans-mucosal Placement of P.004 Implants in the Anterior Maxilla and Mandible by Evaluation of the Change in Bone Level Between 1st Stage Surgery and 6 Months Post Surgery
Status: Enrolling
Updated: 3/2/2016
Dr. Stephen T. Chen
mi
from
Melbourne,
Click here to add this to my saved trials
Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis
Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis
Status: Enrolling
Updated:  3/2/2016
NYU Langone Medical Center
mi
from
New York, NY
Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis
Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis
Status: Enrolling
Updated: 3/2/2016
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of Straumann BoneCeramic vs. Allograft Bone in Extraction Sockets
Comparison of an Alloplast (Straumann Bone Ceramic) to an Allograft of Freeze Dried Bone (FDBA) for Preservation of the Alveolar Ridge Following Tooth Extraction: a Prospective, Randomized, Controlled Clinical Study
Status: Enrolling
Updated:  3/3/2016
Private Practice
mi
from
Yardley, PA
Comparison of Straumann BoneCeramic vs. Allograft Bone in Extraction Sockets
Comparison of an Alloplast (Straumann Bone Ceramic) to an Allograft of Freeze Dried Bone (FDBA) for Preservation of the Alveolar Ridge Following Tooth Extraction: a Prospective, Randomized, Controlled Clinical Study
Status: Enrolling
Updated: 3/3/2016
Private Practice
mi
from
Yardley, PA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Alta Bates Comprehensive Cancer Center
mi
from
Berkley, CA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Alta Bates Comprehensive Cancer Center
mi
from
Berkley, CA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Research Facility
mi
from
La Jolla, CA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Scripps Green Medical Center
mi
from
La Jolla, CA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Scripps Green Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Rocky Mountain Blood and Marrow Transplant Program
mi
from
Denver, CO
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Rocky Mountain Blood and Marrow Transplant Program
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Emory University
mi
from
Atlanta, GA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Northwestern University
mi
from
Chicago, IL
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Rush University Medical Center
mi
from
Chicago, IL
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
St. Francis Hospital and Health Centers
mi
from
Beech Grove, IN
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
St. Francis Hospital and Health Centers
mi
from
Beech Grove, IN
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Louisiana State University Health Science Center
mi
from
Shreveport, LA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Louisiana State University Health Science Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Wayne State University
mi
from
Detroit, MI
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
The Cancer Center, Hackensack University Medical Center
mi
from
Hackensack, NJ
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
The Cancer Center, Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Biomedical Research Alliance of New York
mi
from
Bronx, NY
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Biomedical Research Alliance of New York
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Cornell Medical Center
mi
from
New York, NY
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Biomedical Research Alliance of New York
mi
from
New York, NY
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Biomedical Research Alliance of New York
mi
from
New York, NY
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Duke Univ Med Ctr
mi
from
Durham, NC
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
University Hospitals of Cleveland
mi
from
Cleveland, OH
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
University of Oklahoma
mi
from
Oklahoma City, OK
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Legacy Good Samaritan Hospital and Cancer Center
mi
from
Portland, OR
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Legacy Good Samaritan Hospital and Cancer Center
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Oregon Health and Science University
mi
from
Portland, OR
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Fox Chase-Temple Bone Marrow Transplant Program
mi
from
Philadelphia, PA
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Fox Chase-Temple Bone Marrow Transplant Program
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Roger Williams Medical Center
mi
from
Providence, RI
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Roger Williams Medical Center
mi
from
Providence, RI
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Baylor University Medical Center
mi
from
Dallas, TX
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
University of Texas Health Science Center
mi
from
San Antonio, TX
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated:  3/14/2016
Medical College of Wisonsin
mi
from
Milwaukee, WI
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
A Phase II Randomized Double Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients Receiving Autologous Stem Cell Transplant
Status: Enrolling
Updated: 3/14/2016
Medical College of Wisonsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study to Compare Marginal Bone Loss Around Implants From Two Dental Implant Systems.
An Open, Randomized Study to Compare Two Dental Implant Systems With Regard to Changes in Marginal Bone Level.
Status: Enrolling
Updated:  3/14/2016
Dept. of Implant Dentistry, New York University
mi
from
New York, NY
Study to Compare Marginal Bone Loss Around Implants From Two Dental Implant Systems.
An Open, Randomized Study to Compare Two Dental Implant Systems With Regard to Changes in Marginal Bone Level.
Status: Enrolling
Updated: 3/14/2016
Dept. of Implant Dentistry, New York University
mi
from
New York, NY
Click here to add this to my saved trials
Study to Compare Marginal Bone Loss Around Implants From Two Dental Implant Systems.
An Open, Randomized Study to Compare Two Dental Implant Systems With Regard to Changes in Marginal Bone Level.
Status: Enrolling
Updated:  3/14/2016
Dept. of Prosthodontics, School of Dentistry, University of North Carolina
mi
from
Chapel Hill, NC
Study to Compare Marginal Bone Loss Around Implants From Two Dental Implant Systems.
An Open, Randomized Study to Compare Two Dental Implant Systems With Regard to Changes in Marginal Bone Level.
Status: Enrolling
Updated: 3/14/2016
Dept. of Prosthodontics, School of Dentistry, University of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
ETT Rotation During Nasal Fiberoptic Intubation
Effect of 90° Degree Counterclockwise Rotation of the Endotracheal Tube on Its Advancement Through the Larynx During Nasal Fiberoptic Intubation in Children: A Randomized and Blinded Study
Status: Enrolling
Updated:  3/22/2016
Nemours DuPont Hospital for Children
mi
from
Wilmington, DE
ETT Rotation During Nasal Fiberoptic Intubation
Effect of 90° Degree Counterclockwise Rotation of the Endotracheal Tube on Its Advancement Through the Larynx During Nasal Fiberoptic Intubation in Children: A Randomized and Blinded Study
Status: Enrolling
Updated: 3/22/2016
Nemours DuPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Determine The Efficacy and Safety of Buprenorphine (as NTC-510 and NTC-510A) in Subjects With Pain Following Surgical Extraction of 1 or 2 Third Molars.
Status: Enrolling
Updated:  4/11/2016
PPD Dental Pain Clinic
mi
from
Austin, TX
Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Determine The Efficacy and Safety of Buprenorphine (as NTC-510 and NTC-510A) in Subjects With Pain Following Surgical Extraction of 1 or 2 Third Molars.
Status: Enrolling
Updated: 4/11/2016
PPD Dental Pain Clinic
mi
from
Austin, TX
Click here to add this to my saved trials
Comparison of Oral Hygiene & Root Resorption During Orthodontic Treatment
Comparison of Root Resorption, Microbial Colonization & Gingival Health Between Clear Aligners, Self-Ligating Brackets & Conventional Brackets- A Randomized Controlled Clinical Trial
Status: Enrolling
Updated:  4/16/2016
Orthodontic Center at University of Connecticut Health Center
mi
from
Farmington, CT
Comparison of Oral Hygiene & Root Resorption During Orthodontic Treatment
Comparison of Root Resorption, Microbial Colonization & Gingival Health Between Clear Aligners, Self-Ligating Brackets & Conventional Brackets- A Randomized Controlled Clinical Trial
Status: Enrolling
Updated: 4/16/2016
Orthodontic Center at University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients
A Double-blind, Randomized, Single Dose, Placebo Controlled, Three Part Study to Evaluate the Safety and Tolerability, Efficacy and Dose Response of SAF312 in Postoperative Dental Pain Patients
Status: Enrolling
Updated:  4/26/2016
Jean Brown Research
mi
from
Salt Lake City, UT
To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients
A Double-blind, Randomized, Single Dose, Placebo Controlled, Three Part Study to Evaluate the Safety and Tolerability, Efficacy and Dose Response of SAF312 in Postoperative Dental Pain Patients
Status: Enrolling
Updated: 4/26/2016
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
Massachusetts General Hospital
mi
from
Boston, MA
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
Skulpt, Inc
mi
from
Boston, MA
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
Skulpt, Inc
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated:  5/10/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Study of Electrical Impedance Myography (EIM) in ALS
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
Status: Enrolling
Updated: 5/10/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Use of Radiographic Contrast to Detect Dental Caries
The Use of Radiographic Contrast to Differentiate Cavitated From Non-cavitated Dental Caries
Status: Enrolling
Updated:  5/31/2016
Creighton University School of Dentistry
mi
from
Omaha, NE
Use of Radiographic Contrast to Detect Dental Caries
The Use of Radiographic Contrast to Differentiate Cavitated From Non-cavitated Dental Caries
Status: Enrolling
Updated: 5/31/2016
Creighton University School of Dentistry
mi
from
Omaha, NE
Click here to add this to my saved trials